Skip to main content
. 2013 Jan 15;133(2):346–356. doi: 10.1002/ijc.28030

Figure 5.

Figure 5

Summary of the BEAMing analysis and representative array-CGH profiles from one representative patient. (a) Mutant fraction and call (i.e., either mutant or wildtype) as established by BEAMing for two patients. (b) The upper panel illustrates the array-CGH profile of the primary tumor, the lower panel the corresponding profile established with plasma DNA from Day 3.